The effect of soluble factors from the monocyte/macrophage (M0) on cell proliferation and the functional effects of cell-cell contact on the arachidonic acid (AA) cascade were studied with vascular smooth muscle cells (SMCs). Peripheral blood M0s were isolated by adherence or in a Percoll gradient, and alveolar M0s were obtained by lavage. Conditioned medium (CM) was prepared by preincubating M0s with medium alone or by separating SMC and M0 cocultures by a membrane insert Cell proliferation (image analysis) and 6-ketoprostaglandin F 1<r (6-keto-PGF la , radioimmunoassay) were measured in SMCs. Labeled prostanoids and other eicosanoid metabolites were isolated by high-performance liquid chromatography from SMCs prelabeled with 14 C-AA. M0s did not synthesize 6-keto-PGF Io . The CM enhanced proliferation but did not stimulate 6-keto-PGFi«, synthesis in SMCs. However, cell-cell contact in cocultures of SMCs with the same concentration of M0s used to generate CM resulted in increased 6-keto-PGF la synthesis by SMCs. Since the stimulatory effect of cell contact was not blocked by butylated hydroxytoluene, it could not be attributed to an oxidative burst from M0s. Functional studies showed that the stimulatory effect of cell contact was enhanced by exogenous free AA and by endogenous AA release through A23187. Release of total radioactivity from prelabeled SMCs was enhanced by cell contact, and this effect was blocked by indomethacin (IM). Cell contact did not increase the release of free A A from prelabeled SMCs, even in the presence of IM. Finally, cell contact only stimulated the formation of prostanoids (IM-sensitive eicosanoid metabolites) from prelabeled SMCs. LJpoxygenase and other products of AA were not formed through cell-cell contact. These data showed that M0s express a soluble factor that enhances SMC proliferation without affecting prostanoid synthesis. Subsequent cell contact between SMCs and M0s stimulates prostanoid synthesis, which may possibly serve as a local and focal homeostatic mechanism for the regulation of uncontrolled SMC proliferation in atherogenesis. 12 Atherosclerosis also involves smooth muscle cell (SMC) differentiation and proliferation, processes that are regulated in part by soluble factors from M0s and eicosanoid metabolites from both M0s and From the
T he recruitment of peripheral blood monocytes (M0s) is an early event in the progression of atherosclerosis, and the foam cell that is characteristic of the atherosclerotic lesion is derived from M0s. 12 Atherosclerosis also involves smooth muscle cell (SMC) differentiation and proliferation, processes that are regulated in part by soluble factors from M0s and eicosanoid metabolites from both M0s and M 0 factors on mitogenesis and the inhibition of mitogenesis are difficult to separate in the biology of the cell wall. The effects may be concentration dependent, or there may be alternative mechanisms that permit the separation of stimulatory and inhibitory effects on mitogenesis. For example, cell-cell contact between different cell types in the vessel wall is important in regulating cell proliferation, 31 - 32 and it may be possible that cell-cell contact between SMCs and M0s contributes to the regulation of SMC proliferation by stimulating eicosanoid metabolism.
We have studied the effects of soluble M 0 factors and M0s themselves on proliferation and eicosanoid metabolism in vascular SMCs. The data show that proliferation is stimulated by a soluble factor at a concentration that does not affect eicosanoid metabolism. Cell-cell contact between the same concentration of M0s used to generate conditioned medium (CM) and SMCs leads to the formation of prostanoid but not lipoxygenase or other products of the arachidonic acid (AA) cascade. We suggest that the initial stimulatory effect of a soluble M 0 factor on SMC proliferation is subsequently regulated by a process in which cell-cell contact between proliferating SMCs and recruited M0s generates prostanoids that function as agents for the local and focal homeostatic control of SMC proliferation in the vessel wall during atherogenesis.
Methods

Peripheral Blood Monocytes
Peripheral blood mononuclear cells were obtained by centrifugation of blood from normal human volunteers over Ficoll-Hypaque gradients. 19 - 33 Peripheral blood mononuclear cells were rinsed twice in Seligmann's balanced salt solution containing 2% human albumin and resuspended at 10 7 cells/ml in RPMI 1640 supplemented with 10% fetal bovine serum. Then 5 ml of the cell suspension was added to a 100-mm-diameter plastic Petri dish (No. 25020, Corning Glassworks, Corning, N.Y.) and incubated at 37°C in 95% air/5% CO 2 . Nonadherent cells were removed by rinsing with Seligmann's balanced salt solution/2% albumin, and adherent M0s were harvested with a rubber policeman. The adherent M0s were more than 90% pure by immunofluorescence analysis, were functionally intact as assessed by chemotaxis and phagocytosis, demonstrated 90% or more esterase activity, 19 - 34 and showed greater than 90% viability by trypan blue exclusion. In several experiments, adherent M0s were suspended in cloning medium (see "Smooth Muscle Cells" section in "Methods") or cloning medium containing 5 mM EDTA and incubated for 10 minutes to remove adherent platelets. 35 In other experiments, adherent M0s were lysed by freezing and thawing followed by sonication for 1 minute. No intact cells were visible under the microscope.
Peripheral blood M0s were also isolated from peripheral blood mononuclear cells in a Percoll gradient. 36 - 37 Peripheral blood mononuclear cells were resuspended at 10 cells/ml in RPMI 1640 supplemented with 10% fetal bovine serum, and M0s were separated on a discontinuous gradient prepared from a Percoll stock solution (Pharmacia Fine Chemicals, Uppsala, Sweden). The gradient layers contained 50.0%, 47.5%, 45 .0%, 42.5%, and 37.5% Percoll stock solution diluted with RPMI 1640. The Percoll gradient was centrifuged at 400g for 40 minutes. Percoll M0s were harvested from the top layer and routinely contained 75-90% M0s as identified by a Wright-Giemsa stain.
Alveolar Monocytes
Human alveolar macrophages (an example of a tissue M0) were obtained by bronchoalveolar lavage of nonsmoking normal volunteers as previously described. 38 -39 Briefly, lidocaine spray (1%) was used to anesthetize the upper airway and larynx. The bronchoscope was inserted through the nose and the tip wedged in a distal portion of a right middle lobe bronchus and a bronchus in the lingula of the left upper lobe. Five 20-ml aliquots of 0.15 M NaCl were instilled into each lobe for a total of 200 mj. Recovered lavage fluid was strained with gauze and centrifuged (400g, 10 minutes) to separate the cells. A small aliquot of the lavage fluid was cytocentrifuged, and the pellets were examined microscopically with the use of Diff-Quik stain (AHS del Caribe, Agvada, Puerto Rico). A minimum of 300 cells was counted for each lavage sample, and the average differential count was M0s 84.8%, lymphocytes 13.3%, neutrophils 2.1%, and eosinophils 0.2%.
Conditioned Medium
Supertiatants from M 0 cultures were used as the source of CM. Peripheral blood M0s prepared either by adherence or Percoll gradient and alveolar M0s were suspended at a known cell density in experimental medium or cloning medium. The suspension was incubated for 24 hours at 37°C. The CM was removed from the culture flask and centrifuged at 600g to remove any nonadherent M0s. The CM was used immediately or stored at -20°C until use. Storage did not affect the properties of the CM. In some experiments, the CM was boiled for 10 minutes. In other experiments, M0s were suspended in medium containing 5 jtg/ml LPS (Escnerichia coli WEO27:B8, DIFCO Laboratories, Detroit, Mich.) and incubated for 24 hours to prepare 24-hour CM-LPS. In other experiments, M0s were placed in an insert (Millipore, Belmont, Mass.) containing a Millicell-HA membrane (0.4-^.m pore size) and cocultured for 24 hours with SMCs seeded outside the insert to prevent cell-cell contact. The CM was incubated for different periods of time with SMCs in the presence or absence of 10 mM indomethacin (IM).
Smooth Muscle Cells
Primary cultures of SMCs Were obtained from the dissected medial layer of guinea pig aortas obtained from prepubertal male animals under ether anesthesia. Three guinea pigs were used for each primary culture. The experimental details for the tissue culture procedure are provided elsewhere. 40 SMCs were identified by their reactivity to antibodies against human umbilical artery F-actin, which have been shown to react specifically with muscle actin isoforms. 4142 The medium used for growing cells to confluency (designated growth medium) was prepared from l x Eagle's minimum essential medium containing Hanks' salts and 25 mM N-2-hydroxyethylpiperazine-A^'-2-ethanesulfonic acid buffer (GIBCO, Grand Island, N.Y.) supplemented with 50 jig/ml gentamicin sulfate, 2 mM glutamine, 1 x nonessential amino acids (Microbiological Associates, Walkersville, Md.), 1 mM sodium pyruvate, 1.3 mg/ml NaHCO 3 , and 10% fetal bovine serum (Sterile Systems, Logan, Utah). The medium used for prostanoid studies with confluent SMCs (designated experimental medium) was prepared from growth medium supplemented with l x essential amino acids, l x essential vitamins, and additional fetal bovine serum (final concentration, 20%). The medium used for SMC proliferation (designated cloning medium) contained the same supplements as experimental medium but with only 10% fetal bovine serum.
In proliferation experiments, SMCs (passage level 3 and 3 days after confluence was achieved) were seeded at 80 cells/cm 2 in Falcon single-well (60x15-mm) plates containing 4 ml cloning medium. The same number of cells was seeded in control and treatment plates in each experimental series. Cells were allowed to attach for 18 hours and then treated by the addition of 1 ml cloning medium alone or CM from M 0 cultures. In all cloning studies, cells were re-treated with identical solutions on day 5 of the incubation period. After an 8-day incubation, medium was removed for analysis, and cells were fixed with 3.7% phosphate-buffered formalin and then stained with filtered Giemsa. A relative cell count was obtained from the total cell area on the Falcon plate. Total cell area was measured by image analysis using an Optomax Visual Analysis System (Optomax, Wallis, N.H.). The relation between cell area and cell number was validated by optical microscopy 43 - 47 and with a Coulter Counter.
Radioimmunoassay of 6-Ketoprostaglandin F, a
Tissue cultures were incubated with medium alone, CM, A23187, or LPS. Tissue cultures were also cocultured with M0s added directly to the medium, M0s separated within an insert, or lysed M0s. 6-Ketoprostaglandin F l a (6-keto-PGF la ), the stable metabolite of PGI 2 , was then measured by radioimmunoassay as previously described for SMCs.
192044 - 50 Prostanoid synthesis under all incubation conditions was blocked by 10 jiM IM. Antibodies were kindly supplied by Dr. Lawrence Levine, Brandeis University, Waltham, Mass. The cross-activity of the 6-keto-PGF la antibody was prostaglandin (PG) Ez 0.15%, PGD 2 0.02%, PGF0
.10%, and AA 0.05%. The 6-keto-PGF la antibody unlike the PGE2 antibody did not cross-react with nonenzymatic oxidation products of AA. 51 Data for immunoreactive materials are expressed as nanomoles per culture (mean±SEM).
Labeling of Smooth Muscle Cell Lipids and Measurement of Labeled Arachidonic Acid Metabolites
[U- C]AA (54.5 mCi/ mmol) were purchased from New England Nuclear, Boston, Mass., and SMC lipids were labeled as previously described. 20 - 49 -52 Over 90% of the radioactivity disappeared from the medium during the labeling process, and over 90% of the radioactivity was found in cellular lipid fractions. Total radioactivity release was measured in cultures of prelabeled cells that were incubated at 37°C for 24 hours with fresh medium containing specified additions. The total radioactivity in the medium was divided by the total cellular uptake of the radiolabel and expressed as a percentage of released radioactivity. Labeled metabolites were isolated from the medium by the addition of 0.5 volume ethanol, acidification with formic acid, and extraction with ethyl acetate.
2049 - 52 Recoveries of radioactive prostanoids and free AA were consistently greater than 90% when these compounds were added to the culture medium. Labeled metabolites were separated and identified by high-performance liquid chromatography (HPLC) as previously described. 20 - 49 -52 Fractions were eluted from an Ultrasphere-ODS column by mixtures of acetonitrile/aqueous phosphoric acid. Fractions were collected at 0.5-1.0-minute intervals, counted, and compared with the elution of labeled standard compounds.
Statistics
Results are reported as mean±SEM.
Results
Peripheral Blood Monocytes Express a Soluble Factor Enhancing Smooth Muscle Cell Proliferation That Does Not Stimulate PGI 2 Synthesis in Rapidly Dividing Smooth Muscle Cells
A series of experiments was undertaken with proliferating SMCs ( Table 1) . As expected from other studies, 9 -" CM from peripheral blood M0s stimulated SMC proliferation. The effect was proportional to the preincubation time with M0s and medium (compare 6-hour CM, 12-hour CM, and 24-hour CM data), indicating that increasing amounts of growth factor were expressed during preincubation. The M 0 growth factor was not expressed by platelets trapped in adherent M0s, since an EDTA wash designed to remove platelets 35 did not affect the growth-promoting properties of CM (compare 24-hour CM, 24-hour CM A , and 24-hour CM B data). The M 0 growth factor was heat labile (compare 24-hour CM with 24-hour, boiled CM data), and it is important to note that boiling did not affect the growthpromoting properties of the medium alone (compare data for medium versus boiled medium). The M0 growth factor was increased when LPS was added to the medium during the preincubation process (compare 24-hour CM with 24-hour CM-LPS data). This effect is complex and difficult to interpret. LPS alone stimulated the synthesis of large amounts of PGI 2 , which evidently inhibits SMC proliferation. The inhibitory effect of increased PGI 2 with LPS is blocked when IM is included in the incubation medium, and LPS under this condition actually enhanced SMC proliferation (compare data for medium, medium + LPS, and medium+LPS + IM). LPS also stimulated M0s to express additional growth factor, since the addition of LPS during preincubation enhanced the proliferative response with CM (compare data for medium + LPS+IM with either 24-hour CM-LPS or 24-hour CM-LPS-IM). These data confirmed previous studies showing that M0s express a heat-labile growth factor that is stimulated by LPS. 9 - 11 Other experiments (data not shown) showed that 11-1 in concentrations ranging from 0.01 to 1.0 unit/ml had little effect on SMC proliferation, confirming previous studies that reported that M0s express a soluble growth factor for proliferating SMCs that is different from Il-l. (6) 887±70 (6) 8±1 ( 6-Keto-PGF la , 6-ketoprostaglandin F| a ; CM, conditioned medium; IM, indomethacin; LPS, lipopolysaccharide. Rapidly proliferating smooth muscle cells were incubated with medium alone or with CM obtained by preincubation for 6, 12, or 24 hours with either 1 or 2x10* (cells/ml) peripheral blood monocytes (M0s) (adherence) and diluted 1:5 with medium alone. CM A was obtained with M0s rewashed with phosphate-buffered saline, and CM B was obtained with M0s rewashed with phosphate-buffered saline containing 5 mM EDTA. In some experiments, 5 ^g/ml LPS was added during preincubation (24-hour CM-LPS). In other experiments, CM or medium alone was boiled for 10 minutes. Cells were cloned in medium alone or medium containing 10 /iM IM or 1 /ig/ml LPS. The medium was changed on day 5 of the incubation period. After continued incubation for 3 days in fresh medium, cell number was estimated by image analysis using arbitrary units normalized to medium alone (relative cell number), and 6-keto-PGFi a was measured by radioimmunoassay in nanograms per culture and normalized to medium alone (relative 6-keto-PGF,,,). Normalized data are reported as mean±SEM, and these data were used to calculate a relative prostanoid to cell ratio. Number of incubations is given in parentheses. dium in proliferating SMC cultures incubated with CM was accounted for by an increase in cell number, and in fact the relative prostanoid to cell ratio actually decreased (Table 1) . Prostanoid synthesis was not required for SMC proliferation (compare medium and CM with and without IM). Furthermore, increased prostanoid synthesis leading to a relative prostanoid to cell ratio of 15 in cultures treated with LPS alone diminished SMC proliferation. This effect was not apparent with 24-hour CM-LPS, probably because the increases in both prostanoid and cell number lowered the relative prostanoid to cell ratio to 3. In summary, enhanced clonal growth with SMCs is not dependent 
Monocyte Stimulation of Prostanoid Synthesis in Smooth Muscle Cells: Requirement for Cell Contact in Monocyte Cocultures
Confluent SMCs were incubated with CM from peripheral blood M0s isolated either by adherence or Percoll gradient and alveolar M0s. 6-Keto-PGF,,, synthesis in SMCs was not affected by CM prepared from M0s preincubated in concentrations as high as 10 6 M 0 per milliliter (Figure 1 ). These data are not explained by the absence of soluble factors, since the CM used in this study contained soluble factors that stimulated prostanoid synthesis in other cell types. For example, prostanoid synthesis in human neonatal foreskin fibroblasts was increased by CM prepared from alveolar M0s preincubated in concentrations as low as 3 x 10 4 M 0 per milliliter (data not shown). These data confirmed previous studies with soluble M 0 factors, which showed that these factors have different effects on SMCs and other cell types. Confluent SMCs were then incubated in cocultures containing either peripheral blood M0s or alveolar M0s. The cocultures all expressed increased amounts of 6-keto-PGF la , and this effect was observed by cell-cell contact with M0s in concentrations as low as 2.5 xlO 5 M 0 per mijliliter (Figure 2) . Cocultures with peripheral blood M0s isolated by a Percoll gradient had an unexpectedly large stimulatory effect on prostanoid synthesis (Figure 2 ), but even the CM from these M0s had no effect on prostanoid synthesis in SMCs (Figure 1 vated by an interaction with SMCs to express a soluble factor that stimulates PGI 2 synthesis. To test this hypothesis, CM was prepared by preincubation with either SMCs alone or an SMC/M0 coculture. Separate SMC cultures were then incubated with CM prepared in this way, and the data showed that these CM preparations had no effect on 6-keto-PGFi 0 synthesis (data not shown). These data confirmed that cell-cell contact was required and that the effect of M0s in cocultures was not the result of the expression of a soluble factor from activated M0s.
The potential effects of soluble SMC factors in activating M0s was tested by another experiment in which cocultures of SMCs and M0s were separated by a Millipore membrane insert. This study allowed the interaction of soluble factors while preventing cell-cell contact. The data, summarized in Table 2 , show that cell-cell contact was required for M0s to have a stimulatory effect on 6-keto-PGF la synthesis in SMCs. The insert experiments allowed the CM formed with M0s to interact immediately with SMCs. As a consequence, this study also eliminated the possibility that M0s express a short-lived stimulatory agent that was deactivated during the 24-hour preincubation period before the CM was added to SMCs.
M0s generate reactive oxygen species 55 by processes that are activated by adherence to biological surfaces. 56 As a consequence, M0s oxidize lipids, 57 and oxygencentered radicals from oxidized lipids are well known as agents that enhance prostanoid synthesis in SMCs at the cyclooxygenase step in the AA cascade. 49 Cocultures of M0s and SMCs were, therefore, tested for their effect on prostanoid synthesis in the presence of the antioxidant, butylated hydroxytoluene (BUT). The BHT concentration (40 fiM) was selected because previous studies with SMCs found that BHT at this concentration blocked lipid peroxidation and only slightly diminished prostanoid synthesis. 49 - 52 The data summarized in Table  3 show that 40 /iM BHT diminished absolute prostanoid synthesis in terms of nanomoles per culture, but the Confluent smooth muscle cells were incubated for 24 hours in coculture with peripheral blood monocytes (M0s) (adherence) or alveolar M0s at 5X10 3 cells/ml. Cocultures were compared with and without a Millipore insert. 6-Ketoprostaglandin F, a (6-keto-PGF la ) was measured by radioimmunoassay. The number of incubations is given in parentheses.
stimulatory effect resulting from cell-cell contact (relative content) was not affected by the antioxidant. These data indicate that the generation of lipid peroxides was not responsible for the stimulatory effect of M0s on prostanoid synthesis.
M0s and an equal number of lysed M0s were compared for their effect on SMCs in cocultures ( Figure  3 ). The data show that both M0s and lysed M0s enhance PGI 2 synthesis. Furthermore, the stimulatory factor in lysed M0s was not able to pass through a Millipore membrane insert. These data show that intact M0s were not required, and since M0s and an M 0 lysate had similar effects, it appears that M 0 surface fragments were important in stimulating prostanoid synthesis in SMC cocultures.
Effect of Cell Contact Between Monocytes and Smooth Muscle Cells on the Arachidonic Acid Cascade in Smooth Muscle Cells
A number of functional studies were undertaken to examine the effects of cell contact on prostanoid synthesis in SMCs. PGJ.2 synthesis (by radioimmunoassay) was enhanced in M0/SMC cocultures after a 24-hour incubation period even when large amounts of free AA were included in the incubation medium (Figure 4 ). These data show that the stimulatory effect of cell-cell contact was not overwhelmed by the stimulatory effect of exogenous free AA on PGI 2 synthesis. Similarly, PGI 2 synthesis (by radioimmunoassay) was enhanced in M0/ SMC cocultures after a 24-hour incubation period even when the fatty acid-releasing agent A23187 was included in the incubation medium ( Figure 5 ). These data show that the stimulatory effect of cell-cell contact was not overwhelmed by the stimulatory effect of endogenous AA release on PGI 2 synthesis.
In other experiments, SMCs were prelabeled by the incorporation of [ 14 C]AA into cellular phospholipids, and M0/labeled-SMC cocultures were then incubated for 24 hours. Total radioactivity measured in the incubation medium was greatry enhanced in cocultures, and this effect was abolished when IM was included in the incubation medium ( Figure 6 ). Since total radioactivity includes labeled prostanoids, labeled free AA, and other labeled AA metabolites, the IM data strongly suggest but do not prove that only cyclooxygenase metabolites were increased in the medium from cocultures. In other experiments with A23187 and cyclosporine A, 2049 -50 IM did not abolish the increase in total radioactivity released to the medium from labeled SMCs. Radioactive metabolites in the medium were then separated by HPLC and shown to consist only of increased amounts of 6-keto-PGF lo , PGE2, and three minor fractions that were sensitive to IM and therefore identified as cyclooxygenase products (Figure 7 ). Similar HPLC tracings (data not shown) were obtained when labeled SMCs were incubated with either LPS or bradykinin.
2049 - 50 In contrast to these studies, HPLC tracings (data not shown) obtained when labeled SMCs were incubated with either A23187 or cyclosporine A showed increased amounts of 6-keto-PGF lo , PGE2, free AA, and many other AA metabolites.
-
49
- 50 Furthermore, labeled free AA and other labeled AA metabolites (data not shown) were greatly increased when IM was included with A23187 or cyclosporine A in the incubation medium. These data showed that M0s only stimulated the formation of cyclooxygenase metabolites in SMCs.
The radioactivity in specific HPLC fractions yielded interesting data (Table 4) . Treatment/medium ratios for radioactivity in the 6-keto-PGF la fraction were increased with both M0-labeled SMC cocultures and A23187-labeled SMCs. It is important to note that labeled free AA was not increased in M0-labeled SMC cocultures (treatment/medium ratio for free AA). Previous studies had shown that labeled free AA was not increased when labeled SMCs were incubated with LPS or bradykinin.
-
49
- 50 There was a striking increase in free AA when labeled SMCs were incubated with A23187 (new data in Table 4 ) that did not occur when labeled SMCs were cocultured with M0s (compare treatment/ medium ratios for free AA). This difference between A23187 and M0s could be explained if M0s stimulated both fatty acid release and cyclooxygenase activity while A23187 stimulated only fatty acid release. However, IM uncouples release from cyclooxygenase activity, and IM did not change the treatment/medium ratio for labeled free AA in M 0 cocultures, even though IM further increased the treatment/medium ratio for labeled free AA in cultures treated with the releasing agent A23187. These functional data show that increased prostanoid synthesis in M0/SMC cocultures was not associated with endogenous fatty acid release.
Discussion
There is little doubt that the progression of the atherosclerotic lesion is a fibroproliferative response to injury that results in the proliferation of aortic SMCs. 46 -8 A number of soluble factors regulate cell proliferation by a final common pathway in which they stimulate cells to express growth-promoting agents such as M0-derived growth factor, 9   " 11 Il-l, 12 PDGF, 1314 fibroblast growth factor, 38 transforming growth factor-/3, 59 and other proliferative agents such as autocrine growth factors, 60 which then induce DNA synthesis. 8 suggest that prostanoids downregulate PDGF induction of DNA synthesis. Prostanoids have a local homeostatic role in cellular regulation, 3 " 8 so it would appear that their induction by growth-promoting agents might diminish or even abolish the effect of these agents on SMC proliferation.
Studies reported in the present investigation show that M0s express a soluble factor promoting SMC proliferation that is present in media that have been conditioned by preincubation with M0s, is heat labile, and is stimulated by LPS (Table 1 ). This factor does not stimulate prostanoid synthesis in rapidly dividing cells (Table 1) . Furthermore, CM does not contain a soluble factor that induces prostanoid synthesis in confluent SMCs, (Figure 1 ) even though CM expresses a soluble factor that is highly effective in stimulating prostanoid synthesis in fibroblasts. These studies show that a soluble M 0 factor stimulates SMC proliferation without affecting prostanoid metabolism, and as a consequence, the initial proliferative response of SMCs to recruited M0s may be uncoupled from the local regulatory effects of eicosanoid metabolism on SMCs.
Our studies show that M0s themselves have an unexpected effect on eicosanoid metabolism in SMCs in that cell-cell contact between M0s and SMCs results in the stimulation of prostanoid synthesis in SMCs (Table  2 and Figures 2-5) . The stimulatory effect of M0s is markedly enhanced when M0s are activated by isolation in a Percoll gradient (Figures 2 and 4) . Studies with the antioxidant BHT show that the stimulatory effect of M0s is not merely the result of an oxidative burst in M0s that generates catalytic amounts of hydroperoxy fatty acids (Table 3) . These results indicate that increased prostanoid synthesis is an intrinsic property of M0s that is expressed by cell-cell contact with SMCs. Cocultures of bovine SMCs and endothelial cells (ECs) also contain increased amounts of 6-keto-PGF lo , but this increase is explained by 6-keto-PGFi a that is synthesized in ECs, 61 soluble factors such as PDGF from ECs that stimulate prostanoid synthesis in SMCs, 61 and soluble factors from SMCs that stimulate prostanoid synthesis in ECs. 62 Unlike the SMC/M0 interaction, the SMC/EC interaction involves humoral factors, with cell-cell contact itself having little effect on prostanoid synthesis.
SMCs and M0s accumulate in vascular tissue as the result of the recruitment of peripheral blood M0s and the recruitment and proliferation of SMCs.
1 - 8 The increase in these cells within the vasculature increases the potential for cell-cell contact, a process involved in morphoregulation, 63 which is known to regulate cell proliferation in the vessel wall.
31
-32 Cell-cell contact may contribute to the increase in prostanoid levels found in severe atherosclerosis, 51516 - 54 and increased prostanoid synthesis through cell-cell contact might very well function as a regulatory mechanism for SMC proliferation in established lesions. Atherosclerotic lesions contain unusually high concentrations of 5,8,11-eicosatrienoic acid, which is a well-known characteristic of tissue AA deficiency, 65 and we have previously suggested that uncontrolled atherogenesis may be the result of a relative deficiency in SMC AA that would have as its effect diminished eicosanoid metabolism just when it was needed to regulate SMC proliferation.**- 67 An SMC AA deficiency would have a particularly significant effect when prostanoid synthesis involved in vascular homeostasis is localized by the functional effect of cell-cell contact between SMCs and M0s.
Prostanoids and hydroperoxy and hydroxy fatty acids are synthesized in SMCs and other cell lines by the AA cascade. Confluent smooth muscle cells were prelabeled with 14 C-arachidonic acid (AA) and then incubated with fresh medium alone, with peripheral blood monocytes (M0s, adherence, 10 6 cells/ml), or 1 /ig/ml A23187 in the presence or absence of 10 jiM indomethacin (IM). Metabolites were extracted and separated by high-performance liquid chromatography, and the 6-ketoprostaglandin F,,, (6-keto-PGF la ) and free AA fractions were counted. Different primary cultures were used with M0s and A23187. 70 Lipoxygenase activation was a unique feature of type 1 agents, since these metabolites were not formed when fatty acid release was mimicked by the addition of free AA, 52 so it is unlikely that these metabolites were formed by the redistribution of free AA into other lipid pools. 76 Thus, phorbol esters stimulate prostanoid synthesis in the presence of excess free AA, and phorbol esters stimulate the formation of free AA from endogenous AA and the formation of cyclooxygenase-independent AA derivatives. As a consequence, the demonstration of de novo cyclooxygenase synthesis is not itself sufficient to predict the effects that an agent may have on the intact cell. Functional studies are required to identify the various effects an agent may have on the AA cascade.
PHOSPHOLIP1D-"C-ARACH1DONIC
The present investigation shows clearly that the functional effects of cell-cell contact between M0s and SMCs on the AA cascade in SMCs are in all ways similar to type 2 agents. Cell contact stimulates 6-keto-PGF ltt synthesis in the presence of both large amounts of exogenous AA (Figure 4 ) and of the powerful type 1 AA-releasing agent A23187 ( Figure 5 ). Cell contact stimulates the release of total radioactivity from prelabeled SMCs, and this effect, as would be expected from agonists that act only at the cyclooxygenase step in the AA cascade, is totally blocked by IM ( Figure 6 ). Cell contact does not increase the amount of labeled free AA (Table 4) . Finally, cell contact only stimulates the formation of cyclooxygenase-dependent (IM sensitive) metabolites ( Figure 7) . It is important to note that cell-cell contact between M0s and SMCs does not generate hydroxy and hydroperoxy derivatives of C-AA from prelabeled cells. M0s express oxygencentered radicals 55 -56 that are capable of oxidizing lipids 57 in lipoproteins to hydroxy and hydroperoxy derivatives, but these compounds were not found in cocultures of M0s and prelabeled SMCs. Oxygencentered radicals in oxidized lipoproteins stimulate the formation of large amounts of nonprostanoid oxidation products from prelabeled cells, 49 but unlike preformed lipid peroxides in lipoproteins, M0s have a specific effect on prostanoid synthesis in SMCs rather than a general effect on fatty acid oxidation.
The peripheral blood M 0 evidently has important properties that allow it to function effectively in the response-to-injury process that maintains the integrity of the vasculature. M0s express a soluble factor that stimulates SMC proliferation without affecting prostanoid synthesis. Functional studies with intact cells show that later cell-cell contact between recruited M0s and proliferating SMCs may generate PGI 2 , which is capable of downregulating SMC proliferation (Table 1) . These functional studies also show that cell-cell contact does not generate hydroxy fatty acids, which are capable of enhancing injury. Cell-cell contact is being increasingly recognized as an important part of morphoregulation.
-
32
- 63 We suggest that cell-cell contact between SMCs and recruited M0s participates in local and focal homeostatic control of fatty streak formation in the aorta through PGI 2 synthesis and that the disruption of this homeostatic control mechanism, possibly through a relative deficiency in A A, 67 is one of the many causes leading to the progression of atherosclerosis.
